Zis P, Hadjivassiliou M (2019). «Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease.». Curr Treat Options Neurol21 (3): 10. doi:10.1007/s11940-019-0552-7. PMID30806821.
Allen, R; Picchietti, D; Hening, WA; Trenkwalder, C; Walters, AS; Montplaisi, J; Restless Legs Syndrome Diagnosis Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group (2003). «Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health». Sleep Medicine4 (2): 101–19. doi:10.1016/S1389-9457(03)00010-8. PMID14592341.
Earley, Christopher J.; Silber, Michael H. (2010). «Restless legs syndrome: Understanding its consequences and the need for better treatment». Sleep Medicine11 (9): 807–15. doi:10.1016/j.sleep.2010.07.007. PMID20817595.
Xiong, L.; Montplaisir, J.; Desautels, A.; Barhdadi, A.; Turecki, G.; Levchenko, A.; Thibodeau, P.; Dubé, M. P. και άλλοι. (2010). «Family Study of Restless Legs Syndrome in Quebec, Canada: Clinical Characterization of 671 Familial Cases». Archives of Neurology67 (5): 617–22. doi:10.1001/archneurol.2010.67. PMID20457962.
Cortese, S; Konofal, E; Lecendreux, M; Arnulf, I; Mouren, MC; Darra, F; Dalla Bernardina, B (2005). «Restless legs syndrome and attention-deficit/hyperactivity disorder: A review of the literature». Sleep28 (8): 1007–13. doi:10.1093/sleep/28.8.1007. PMID16218085.
Allen, R (2004). «Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)». Sleep Medicine5 (4): 385–91. doi:10.1016/j.sleep.2004.01.012. PMID15222997.
Clemens, S.; Rye, D; Hochman, S (2006). «Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective». Neurology67 (1): 125–130. doi:10.1212/01.wnl.0000223316.53428.c9. PMID16832090.
Dauvilliers, Yves; Winkelmann, Juliane (2013-11-01). «Restless legs syndrome: update on pathogenesis» (στα αγγλικά). Current Opinion in Pulmonary Medicine19 (6): 594–600. doi:10.1097/MCP.0b013e328365ab07. ISSN1070-5287. PMID24048084.
Klein, Marianne O.; Battagello, Daniella S.; Cardoso, Ariel R.; Hauser, David N.; Bittencourt, Jackson C.; Correa, Ricardo G. (2019-01-01). «Dopamine: Functions, Signaling, and Association with Neurological Diseases» (στα αγγλικά). Cellular and Molecular Neurobiology39 (1): 31–59. doi:10.1007/s10571-018-0632-3. ISSN1573-6830. PMID30446950.
Garcia-Borreguero, Diego; Williams, Anne-Marie (2014-08-01). «An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment» (στα αγγλικά). Current Opinion in Neurology27 (4): 493–501. doi:10.1097/WCO.0000000000000117. ISSN1350-7540. PMID24978636.
Paulus, Walter; Trenkwalder, Claudia (2006-10-01). «Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome». The Lancet Neurology5 (10): 878–886. doi:10.1016/S1474-4422(06)70576-2. ISSN1474-4422. PMID16987735.
Allen, Richard P.; Montplaisir, Jacques; Walters, Arthur Scott; Ferini-Strambi, Luigi; Högl, Birgit (2017), «Restless Legs Syndrome and Periodic Limb Movements During Sleep», Principles and Practice of Sleep Medicine (Elsevier): 923–934.e6, doi:10.1016/b978-0-323-24288-2.00095-7, ISBN9780323242882
Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianni (2007-01-04). «Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease». New England Journal of Medicine356 (1): 39–46. doi:10.1056/NEJMoa054830. ISSN0028-4793. PMID17202454.
Mackie, Susan; Winkelman, John W. (2015-05-01). «Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation» (στα αγγλικά). CNS Drugs29 (5): 351–357. doi:10.1007/s40263-015-0250-2. ISSN1179-1934. PMID26045290.
Quilici, S; Abrams, KR; Nicolas, A; Martin, M; Petit, C; Lleu, PL; Finnern, HW (Oct 2008). «Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.». Sleep Medicine9 (7): 715–26. doi:10.1016/j.sleep.2007.11.020. PMID18226947.
Tippmann-Peikert, M.; Park, J. G.; Boeve, B. F.; Shepard, J. W.; Silber, M. H. (2007). «Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists». Neurology68 (4): 301–3. doi:10.1212/01.wnl.0000252368.25106.b6. PMID17242339 (February 9, 2007).
Nagandla, K; De, S (July 2013). «Restless legs syndrome: pathophysiology and modern management.». Postgraduate Medical Journal89 (1053): 402–10. doi:10.1136/postgradmedj-2012-131634. PMID23524988.
Allen, R. P.; Walters, AS; Montplaisir, J; Hening, W; Myers, A; Bell, TJ; Ferini-Strambi, L (2005). «Restless Legs Syndrome Prevalence and Impact: REST General Population Study». Archives of Internal Medicine165 (11): 1286–92. doi:10.1001/archinte.165.11.1286. PMID15956009.
Berger, K.; Luedemann, J; Trenkwalder, C; John, U; Kessler, C (2004). «Sex and the Risk of Restless Legs Syndrome in the General Population». Archives of Internal Medicine164 (2): 196–202. doi:10.1001/archinte.164.2.196. PMID14744844.
Lee, Kathryn A.; Zaffke, Mary Ellen; Baratte-Beebe, Kathleen (2001). «Restless Legs Syndrome and Sleep Disturbance during Pregnancy: The Role of Folate and Iron». Journal of Women's Health & Gender-Based Medicine10 (4): 335–41. doi:10.1089/152460901750269652. PMID11445024.
Yeh, Paul; Walters, Arthur S.; Tsuang, John W. (1 December 2012). «Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment». Sleep & Breathing = Schlaf & Atmung16 (4): 987–1007. doi:10.1007/s11325-011-0606-x. ISSN1522-1709. PMID22038683.
Hening, Wayne; Allen, Richard; Earley, Christopher; Kushida, Clete; Picchietti, Daniel; Silber, Michael (1999). «The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder». Sleep. doi:10.1093/sleep/22.7.970.
Coccagna, G; Vetrugno, R; Lombardi, C; Provini, F (2004). «Restless legs syndrome: an historical note». Sleep Medicine5 (3): 279–83. doi:10.1016/j.sleep.2004.01.002. PMID15165536.
Konofal, Eric; Karroum, Elias; Montplaisir, Jacques; Derenne, Jean-Philippe; Arnulf, Isabelle (2009). «Two early descriptions of restless legs syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898)». Sleep Medicine10 (5): 586–91. doi:10.1016/j.sleep.2008.04.008. PMID18752999.
«Restless legs syndrome». MedlinePlus, US National Library of Medicine, National Institutes of Health. 7 Αυγούστου 2017. Ανακτήθηκε στις 23 Ιουνίου 2019.
Ramar, K; Olson, EJ (Aug 15, 2013). «Management of common sleep disorders.». American Family Physician88 (4): 231–8. PMID23944726.
Zis P, Hadjivassiliou M (2019). «Treatment of Neurological Manifestations of Gluten Sensitivity and Coeliac Disease.». Curr Treat Options Neurol21 (3): 10. doi:10.1007/s11940-019-0552-7. PMID30806821.
Allen, R; Picchietti, D; Hening, WA; Trenkwalder, C; Walters, AS; Montplaisi, J; Restless Legs Syndrome Diagnosis Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group (2003). «Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health». Sleep Medicine4 (2): 101–19. doi:10.1016/S1389-9457(03)00010-8. PMID14592341.
Earley, Christopher J.; Silber, Michael H. (2010). «Restless legs syndrome: Understanding its consequences and the need for better treatment». Sleep Medicine11 (9): 807–15. doi:10.1016/j.sleep.2010.07.007. PMID20817595.
Xiong, L.; Montplaisir, J.; Desautels, A.; Barhdadi, A.; Turecki, G.; Levchenko, A.; Thibodeau, P.; Dubé, M. P. και άλλοι. (2010). «Family Study of Restless Legs Syndrome in Quebec, Canada: Clinical Characterization of 671 Familial Cases». Archives of Neurology67 (5): 617–22. doi:10.1001/archneurol.2010.67. PMID20457962.
Cortese, S; Konofal, E; Lecendreux, M; Arnulf, I; Mouren, MC; Darra, F; Dalla Bernardina, B (2005). «Restless legs syndrome and attention-deficit/hyperactivity disorder: A review of the literature». Sleep28 (8): 1007–13. doi:10.1093/sleep/28.8.1007. PMID16218085.
Trenkwalder, Claudia; Zieglgänsberger, Walter; Ahmedzai, Sam H.; Högl, Birgit (2017). «Pain, opioids, and sleep: implications for restless legs syndrome treatment». Sleep Medicine31: 78–85. doi:10.1016/j.sleep.2016.09.017. ISSN1389-9457. PMID27964861.
Lavigne, GJ; Montplaisir, JY (1994). «Restless legs syndrome and sleep bruxism: prevalence and association among Canadians». Sleep17 (8): 739–43. PMID7701186.
Allen, R (2004). «Dopamine and iron in the pathophysiology of restless legs syndrome (RLS)». Sleep Medicine5 (4): 385–91. doi:10.1016/j.sleep.2004.01.012. PMID15222997.
Clemens, S.; Rye, D; Hochman, S (2006). «Restless legs syndrome: Revisiting the dopamine hypothesis from the spinal cord perspective». Neurology67 (1): 125–130. doi:10.1212/01.wnl.0000223316.53428.c9. PMID16832090.
Dauvilliers, Yves; Winkelmann, Juliane (2013-11-01). «Restless legs syndrome: update on pathogenesis» (στα αγγλικά). Current Opinion in Pulmonary Medicine19 (6): 594–600. doi:10.1097/MCP.0b013e328365ab07. ISSN1070-5287. PMID24048084.
Klein, Marianne O.; Battagello, Daniella S.; Cardoso, Ariel R.; Hauser, David N.; Bittencourt, Jackson C.; Correa, Ricardo G. (2019-01-01). «Dopamine: Functions, Signaling, and Association with Neurological Diseases» (στα αγγλικά). Cellular and Molecular Neurobiology39 (1): 31–59. doi:10.1007/s10571-018-0632-3. ISSN1573-6830. PMID30446950.
Garcia-Borreguero, Diego; Williams, Anne-Marie (2014-08-01). «An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment» (στα αγγλικά). Current Opinion in Neurology27 (4): 493–501. doi:10.1097/WCO.0000000000000117. ISSN1350-7540. PMID24978636.
Paulus, Walter; Trenkwalder, Claudia (2006-10-01). «Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome». The Lancet Neurology5 (10): 878–886. doi:10.1016/S1474-4422(06)70576-2. ISSN1474-4422. PMID16987735.
Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianni (2007-01-04). «Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease». New England Journal of Medicine356 (1): 39–46. doi:10.1056/NEJMoa054830. ISSN0028-4793. PMID17202454.
Mackie, Susan; Winkelman, John W. (2015-05-01). «Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation» (στα αγγλικά). CNS Drugs29 (5): 351–357. doi:10.1007/s40263-015-0250-2. ISSN1179-1934. PMID26045290.
Quilici, S; Abrams, KR; Nicolas, A; Martin, M; Petit, C; Lleu, PL; Finnern, HW (Oct 2008). «Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.». Sleep Medicine9 (7): 715–26. doi:10.1016/j.sleep.2007.11.020. PMID18226947.
Tippmann-Peikert, M.; Park, J. G.; Boeve, B. F.; Shepard, J. W.; Silber, M. H. (2007). «Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists». Neurology68 (4): 301–3. doi:10.1212/01.wnl.0000252368.25106.b6. PMID17242339 (February 9, 2007).
Nagandla, K; De, S (July 2013). «Restless legs syndrome: pathophysiology and modern management.». Postgraduate Medical Journal89 (1053): 402–10. doi:10.1136/postgradmedj-2012-131634. PMID23524988.
Allen, R. P.; Walters, AS; Montplaisir, J; Hening, W; Myers, A; Bell, TJ; Ferini-Strambi, L (2005). «Restless Legs Syndrome Prevalence and Impact: REST General Population Study». Archives of Internal Medicine165 (11): 1286–92. doi:10.1001/archinte.165.11.1286. PMID15956009.
Berger, K.; Luedemann, J; Trenkwalder, C; John, U; Kessler, C (2004). «Sex and the Risk of Restless Legs Syndrome in the General Population». Archives of Internal Medicine164 (2): 196–202. doi:10.1001/archinte.164.2.196. PMID14744844.
Lee, Kathryn A.; Zaffke, Mary Ellen; Baratte-Beebe, Kathleen (2001). «Restless Legs Syndrome and Sleep Disturbance during Pregnancy: The Role of Folate and Iron». Journal of Women's Health & Gender-Based Medicine10 (4): 335–41. doi:10.1089/152460901750269652. PMID11445024.
Yeh, Paul; Walters, Arthur S.; Tsuang, John W. (1 December 2012). «Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment». Sleep & Breathing = Schlaf & Atmung16 (4): 987–1007. doi:10.1007/s11325-011-0606-x. ISSN1522-1709. PMID22038683.
Coccagna, G; Vetrugno, R; Lombardi, C; Provini, F (2004). «Restless legs syndrome: an historical note». Sleep Medicine5 (3): 279–83. doi:10.1016/j.sleep.2004.01.002. PMID15165536.
Konofal, Eric; Karroum, Elias; Montplaisir, Jacques; Derenne, Jean-Philippe; Arnulf, Isabelle (2009). «Two early descriptions of restless legs syndrome and periodic leg movements by Boissier de Sauvages (1763) and Gilles de la Tourette (1898)». Sleep Medicine10 (5): 586–91. doi:10.1016/j.sleep.2008.04.008. PMID18752999.
Teive, Hélio A.G.; Munhoz, Renato P.; Barbosa, Egberto Reis (2009). «Professor Karl-Axel Ekbom and restless legs syndrome». Parkinsonism & Related Disorders15 (4): 254–7. doi:10.1016/j.parkreldis.2008.07.011. PMID18829374.
Dauvilliers, Yves; Winkelmann, Juliane (2013-11-01). «Restless legs syndrome: update on pathogenesis» (στα αγγλικά). Current Opinion in Pulmonary Medicine19 (6): 594–600. doi:10.1097/MCP.0b013e328365ab07. ISSN1070-5287. PMID24048084.
Klein, Marianne O.; Battagello, Daniella S.; Cardoso, Ariel R.; Hauser, David N.; Bittencourt, Jackson C.; Correa, Ricardo G. (2019-01-01). «Dopamine: Functions, Signaling, and Association with Neurological Diseases» (στα αγγλικά). Cellular and Molecular Neurobiology39 (1): 31–59. doi:10.1007/s10571-018-0632-3. ISSN1573-6830. PMID30446950.
Garcia-Borreguero, Diego; Williams, Anne-Marie (2014-08-01). «An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment» (στα αγγλικά). Current Opinion in Neurology27 (4): 493–501. doi:10.1097/WCO.0000000000000117. ISSN1350-7540. PMID24978636.
Paulus, Walter; Trenkwalder, Claudia (2006-10-01). «Less is more: pathophysiology of dopaminergic-therapy-related augmentation in restless legs syndrome». The Lancet Neurology5 (10): 878–886. doi:10.1016/S1474-4422(06)70576-2. ISSN1474-4422. PMID16987735.
Zanettini, Renzo; Antonini, Angelo; Gatto, Gemma; Gentile, Rosa; Tesei, Silvana; Pezzoli, Gianni (2007-01-04). «Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease». New England Journal of Medicine356 (1): 39–46. doi:10.1056/NEJMoa054830. ISSN0028-4793. PMID17202454.
Mackie, Susan; Winkelman, John W. (2015-05-01). «Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation» (στα αγγλικά). CNS Drugs29 (5): 351–357. doi:10.1007/s40263-015-0250-2. ISSN1179-1934. PMID26045290.
Yeh, Paul; Walters, Arthur S.; Tsuang, John W. (1 December 2012). «Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment». Sleep & Breathing = Schlaf & Atmung16 (4): 987–1007. doi:10.1007/s11325-011-0606-x. ISSN1522-1709. PMID22038683.